ADMA: a novel risk factor that explains excess cardiovascular event rate in patients with end-stage renal disease

Author： Boger R.H.   Zoccali C.  

Publisher： Elsevier

ISSN： 1567-5688

Source： Atherosclerosis, Supplements, Vol.4, Iss.4, 2003-12, pp. : 23-28

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Improved survival rate in patients with diabetes and end-stage renal disease in Denmark

By Sørensen V.   Mathiesen E.   Heaf J.   Feldt-Rasmussen B.  

Diabetologia, Vol. 50, Iss. 5, 2007-05 ,pp. : 922-929

Springer Publishing Company

Access to resources Recommend Favorite

Periprocedural Risk of Stroke Is Elevated in Patients with End-Stage Renal Disease on Hemodialysis

By  

Cerebrovascular Diseases Extra, Vol. 5, Iss. 3, 2015-0 ,pp. : 91-94

Karger

Access to resources Recommend Favorite

Calciphylaxis in end-stage renal disease patients

By Verdalles Ursula   García de Vinuesa Soledad   Luño José  

Nephrology Dialysis Transplantation, Vol. 27, Iss. 9, 2012-09 ,pp. : 3663-3663

Oxford University Press

Access to resources Recommend Favorite

Editorial: [Statins and Cardiovascular Events in Patients with End-Stage Renal Disease on Hemodialysis. The AURORA Results Suggest the Need for Earlier Intervention]

By  

Current Vascular Pharmacology, Vol. 7, Iss. 3, 2009-07 ,pp. : 264-266

Bentham Science Publishers

Access to resources Recommend Favorite

Diagnosis and Management of Cardiovascular Disease in Advanced and End‐Stage Renal Disease

By  

JOURNAL OF THE AMERICAN HEART ASSOCIATION, Vol. 5, Iss. 8, 2016-08 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite